DexCom Inc (DXCM)
Quick ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cash | US$ in thousands | 566,300 | 642,300 | 1,052,600 | 817,600 | 446,200 |
Short-term investments | US$ in thousands | 2,160,000 | 1,810,000 | 1,360,000 | 1,890,100 | 1,087,100 |
Receivables | US$ in thousands | 987,500 | 752,200 | 514,300 | 428,500 | 286,300 |
Total current liabilities | US$ in thousands | 1,556,000 | 1,839,300 | 720,800 | 614,100 | 360,200 |
Quick ratio | 2.39 | 1.74 | 4.06 | 5.11 | 5.05 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($566,300K
+ $2,160,000K
+ $987,500K)
÷ $1,556,000K
= 2.39
The quick ratio of Dexcom Inc has shown fluctuations over the past five years. In 2023, the quick ratio stands at 2.48, indicating that the company has $2.48 in liquid assets available to cover each dollar of current liabilities. This represents an improvement compared to 2022 when the quick ratio was 1.83.
The quick ratio was significantly higher in 2021 at 4.62, reflecting a strong ability to meet short-term obligations using liquid assets. In 2020 and 2019, the quick ratios were 5.19 and 5.13 respectively, demonstrating consistent high liquidity levels over those years.
Overall, the quick ratio of Dexcom Inc has fluctuated but has generally remained at healthy levels, suggesting the company's ability to meet its short-term financial obligations using its liquid assets. However, a decreasing trend in recent years warrants further monitoring to ensure continued liquidity strength.
Peer comparison
Dec 31, 2023